{
    "id": "New-v26-a7b8c9d0-e1f2-4344-b5a6-789012345678",
    "type": "clozeDropdown",
    "stem": "The nurse is updating the client's electronic health record. Complete the following sentence. The client's serum ammonia of [dropdown1] mcg/dL and [dropdown2] mental status are critical findings requiring immediate intervention with [dropdown3] to manage worsening hepatic encephalopathy.",
    "scoring": {
        "method": "0/1",
        "maxPoints": 3
    },
    "itemContext": {
        "patient": {
            "name": "John Smith",
            "age": 62,
            "sex": "Male",
            "pronouns": "He/Him",
            "iso": "Medical Surgical Unit",
            "allergies": [
                "Penicillin"
            ]
        },
        "tabs": [
            {
                "id": "clinicalFeed",
                "title": "Clinical Feed",
                "notes": [
                    {
                        "type": "Admission Note",
                        "timestamp": "Day 1, 02:30",
                        "content": "S: 62-year-old male admitted from the emergency department with acute-on-chronic pancreatitis and decompensated cirrhosis. Reports 3 days of worsening epigastric pain radiating to the back, nausea, and significant abdominal swelling.\nB: History of alcohol use disorder, diagnosed with cirrhosis 5 years prior. Reports poor adherence with prescribed lactulose and spironolactone. Patient reports living alone with limited social support and financial strain, which he states delayed seeking care. Known allergy to Penicillin.\nA: On admission, patient is drowsy but oriented to person, place, and time. Skin is jaundiced with scattered ecchymoses on bilateral upper extremities. Abdomen is protuberant, firm, with a positive fluid wave. Mild scleral icterus noted. No asterixis observed initially.\nR: Admit to the medical-surgical unit for management of pancreatitis and decompensated liver disease. Initiate IV fluids, pain management, and restart home medications. Monitor vital signs, mental status, and fluid balance closely."
                    },
                    {
                        "type": "Progress Note",
                        "timestamp": "Day 2, 07:00",
                        "content": "S: Patient is now increasingly confused and disoriented to time and place. Adult child at bedside is concerned about his lethargy and slurred speech.\nB: The client has a known history of cirrhosis and was admitted for acute pancreatitis. His ammonia level on admission was elevated. Last dose of lactulose was administered at 06:00, but he has not yet had a bowel movement.\nA: Neurological assessment reveals orientation to self only. Asterixis is now present with dorsiflexion of the hands. Abdomen remains distended and tense. Fetor hepaticus is now detectable on breath. Vital signs show a trend towards tachycardia and tachypnea. SpO2 is slightly lower at 95% on room air.\nR: Recommend STAT repeat serum ammonia level. Continue close neurological monitoring every hour. Prepare to administer additional lactulose as per orders. Notified provider of acute change in mental status; awaiting response."
                    }
                ]
            },
            {
                "id": "vitals",
                "title": "Vitals & Telemetry",
                "flowsheet": [
                    {
                        "Time": "Day 1, 02:30",
                        "HR (bpm)": "85",
                        "BP (mmHg)": "118/76 (90)",
                        "RR (breaths/min)": "18",
                        "SpO₂ (%)": "97% on RA",
                        "Temp °F (°C)": "99.1 (37.3)"
                    },
                    {
                        "Time": "Day 2, 06:00",
                        "HR (bpm)": "88",
                        "BP (mmHg)": "112/72 (85)",
                        "RR (breaths/min)": "20",
                        "SpO₂ (%)": "97% on RA",
                        "Temp °F (°C)": "99.2 (37.3)"
                    },
                    {
                        "Time": "Day 2, 07:15",
                        "HR (bpm)": "94",
                        "BP (mmHg)": "108/68 (81)",
                        "RR (breaths/min)": "24",
                        "SpO₂ (%)": "95% on RA",
                        "Temp °F (°C)": "99.7 (37.6)"
                    }
                ]
            },
            {
                "id": "labs",
                "title": "Lab Diagnostics",
                "results": [
                    {
                        "Test": "Ammonia",
                        "Result": "180",
                        "Unit": "mcg/dL",
                        "Reference": "15-45",
                        "Status": "High"
                    },
                    {
                        "Test": "Bilirubin, Total",
                        "Result": "4.2",
                        "Unit": "mg/dL",
                        "Reference": "0.3-1.0",
                        "Status": "High"
                    },
                    {
                        "Test": "Albumin",
                        "Result": "2.8",
                        "Unit": "g/dL",
                        "Reference": "3.5-5.0",
                        "Status": "Low"
                    },
                    {
                        "Test": "AST",
                        "Result": "150",
                        "Unit": "U/L",
                        "Reference": "10-40",
                        "Status": "High"
                    },
                    {
                        "Test": "ALT",
                        "Result": "175",
                        "Unit": "U/L",
                        "Reference": "7-56",
                        "Status": "High"
                    },
                    {
                        "Test": "INR",
                        "Result": "1.8",
                        "Unit": "",
                        "Reference": "0.8-1.1",
                        "Status": "High"
                    },
                    {
                        "Test": "Sodium",
                        "Result": "138",
                        "Unit": "mEq/L",
                        "Reference": "135-145",
                        "Status": ""
                    },
                    {
                        "Test": "Potassium",
                        "Result": "3.8",
                        "Unit": "mEq/L",
                        "Reference": "3.5-5.0",
                        "Status": ""
                    }
                ]
            },
            {
                "id": "physicalExam",
                "title": "Physical Exam",
                "assessments": [
                    {
                        "type": "Admission Assessment",
                        "timestamp": "Day 1, 02:30",
                        "findings": "GENERAL: Appears fatigued but in no acute distress. Drowsy.\nNEUROLOGICAL: Alert and oriented to person, place, and time. GCS 15. No asterixis.\nCARDIOVASCULAR: S1, S2 audible. Rate regular. No murmurs. Capillary refill <3 seconds.\nRESPIRATORY: Lungs clear to auscultation bilaterally. Breathing unlabored.\nGASTROINTESTINAL: Abdomen protuberant, firm, with positive fluid wave and shifting dullness. Bowel sounds hypoactive. Epigastric tenderness on palpation.\nINTEGUMENTARY: Skin warm, dry, with notable jaundice. Scleral icterus present. Multiple ecchymotic areas on arms."
                    },
                    {
                        "type": "Focused Assessment",
                        "timestamp": "Day 2, 07:00",
                        "findings": "NEUROLOGICAL: Lethargic, slow to respond to questions. Oriented to self only. Speech is slurred. Asterixis ('liver flap') is now present upon dorsiflexion of the wrists. GCS 13 (E3, V4, M6).\nGASTROINTESTINAL: Abdomen remains distended and tense. No bowel movement reported overnight. Fetor hepaticus noted."
                    }
                ]
            },
            {
                "id": "radiology",
                "title": "Radiology",
                "reports": [
                    {
                        "type": "Abdominal Ultrasound",
                        "timestamp": "Day 1, 09:00",
                        "report": "FINDINGS: The liver demonstrates a nodular contour and coarse echotexture, consistent with advanced cirrhosis. Moderate to large volume ascites is present. The pancreas appears edematous and inflamed, suggestive of acute pancreatitis. No evidence of cholelithiasis or biliary ductal dilation.\nIMPRESSION: Findings are consistent with acute-on-chronic pancreatitis in the setting of advanced cirrhosis with significant ascites."
                    }
                ]
            },
            {
                "id": "carePlan",
                "title": "Care Plan",
                "orders": [
                    {
                        "timestamp": "Day 1, 02:45",
                        "action": "Admit to Medical-Surgical Unit",
                        "status": "Active"
                    },
                    {
                        "timestamp": "Day 1, 02:45",
                        "action": "NPO",
                        "status": "Active"
                    },
                    {
                        "timestamp": "Day 1, 02:45",
                        "action": "Lactated Ringer's at 125 mL/hr",
                        "status": "Active"
                    },
                    {
                        "timestamp": "Day 1, 02:45",
                        "action": "Neurological checks every 4 hours",
                        "status": "Active"
                    },
                    {
                        "timestamp": "Day 1, 02:45",
                        "action": "STAT Comprehensive Metabolic Panel, CBC, Amylase, Lipase, Ammonia, Coagulation Panel",
                        "status": "Completed"
                    },
                    {
                        "timestamp": "Day 2, 07:30",
                        "action": "STAT repeat serum Ammonia level",
                        "status": "New"
                    }
                ]
            },
            {
                "id": "mar",
                "title": "MAR Console",
                "medications": [
                    {
                        "medication": "Lactulose",
                        "dose": "30 mL",
                        "route": "PO",
                        "frequency": "q6h",
                        "lastAdministered": "Day 2, 06:00"
                    },
                    {
                        "medication": "Spironolactone",
                        "dose": "100 mg",
                        "route": "PO",
                        "frequency": "Daily",
                        "lastAdministered": "Day 2, 06:00"
                    },
                    {
                        "medication": "Hydromorphone",
                        "dose": "0.5 mg",
                        "route": "IV",
                        "frequency": "q4h PRN for pain",
                        "lastAdministered": "Day 1, 22:00"
                    },
                    {
                        "medication": "Multivitamin",
                        "dose": "1 tablet",
                        "route": "PO",
                        "frequency": "Daily",
                        "lastAdministered": "Day 2, 06:00"
                    }
                ]
            }
        ]
    },
    "pedagogy": {
        "bloomLevel": "analyze",
        "cjmmStep": "analyzeCues",
        "nclexCategory": "Pharmacological and Parenteral Therapies",
        "difficulty": 5,
        "topicTags": [
            "GI/Hepatic: Liver Failure & Pancreatitis"
        ]
    },
    "rationale": {
        "correct": "The client's clinical presentation, including a critically elevated serum ammonia of 180 mcg/dL, declining mental status (confusion, lethargy, asterixis), and history of cirrhosis, strongly indicates worsening hepatic encephalopathy. This condition results from the liver's inability to detoxify ammonia, a neurotoxin. The priority intervention is administering lactulose, an osmotic laxative that lowers ammonia levels by acidifying the gut, converting ammonia (NH3) to ammonium (NH4+), which is then trapped in the colon and excreted in the feces.",
        "incorrect": "Incorrectly identifying the ammonia level, mental status, or priority medication demonstrates a failure to synthesize critical data. An ammonia level of 80 mcg/dL is only mildly elevated and does not match the severity of the client's neurological decline. Describing the mental status as 'stable' or 'unchanged' directly contradicts the evidence in the progress note. Selecting furosemide, neomycin, or albumin is incorrect. Furosemide addresses ascites, not the underlying hyperammonemia. Neomycin is a second-line agent with significant toxicity risks. Albumin is used for volume expansion or spontaneous bacterial peritonitis prophylaxis, not for acute encephalopathy.",
        "answerBreakdown": [
            {
                "dropdownId": "dropdown1",
                "option": "80",
                "isCorrect": false,
                "content": "Incorrect. An ammonia level of 80 mcg/dL is at the upper limit of normal or only mildly elevated. This value does not correlate with the severe neurological symptoms of asterixis and disorientation to time and place, indicating a more severe pathology."
            },
            {
                "dropdownId": "dropdown1",
                "option": "120",
                "isCorrect": false,
                "content": "Incorrect. While 120 mcg/dL is elevated and concerning, the lab report shows a value of 180 mcg/dL. The nurse must report the actual, critical value from the diagnostic report to ensure appropriate and timely intervention."
            },
            {
                "dropdownId": "dropdown1",
                "option": "180",
                "isCorrect": true,
                "content": "Correct. This value matches the critical finding in the client's lab report. A serum ammonia level of 180 mcg/dL is significantly elevated and directly explains the acute neurological deterioration characteristic of hepatic encephalopathy."
            },
            {
                "dropdownId": "dropdown1",
                "option": "250",
                "isCorrect": false,
                "content": "Incorrect. This value is not supported by the client's lab report. While a level this high would also be critical, accurate documentation requires using the precise value obtained from the diagnostic test."
            },
            {
                "dropdownId": "dropdown2",
                "option": "improved",
                "isCorrect": false,
                "content": "Incorrect. The progress note explicitly states the client is 'increasingly confused and disoriented' and has developed asterixis, which is a clear sign of neurological deterioration, not improvement."
            },
            {
                "dropdownId": "dropdown2",
                "option": "unchanged",
                "isCorrect": false,
                "content": "Incorrect. The client's mental status has significantly changed from the admission assessment (A&O x3) to the current assessment (A&O x1 with lethargy and asterixis), indicating a worsening, not an unchanged, condition."
            },
            {
                "dropdownId": "dropdown2",
                "option": "declining",
                "isCorrect": true,
                "content": "Correct. The client's progression from being oriented on admission to being disoriented with new-onset asterixis and lethargy represents a significant neurological decline, consistent with worsening hepatic encephalopathy."
            },
            {
                "dropdownId": "dropdown2",
                "option": "stable",
                "isCorrect": false,
                "content": "Incorrect. The term 'stable' implies no significant change. The evidence in the chart, including the new onset of asterixis and increased confusion, clearly shows the client's condition is unstable and deteriorating."
            },
            {
                "dropdownId": "dropdown3",
                "option": "furosemide",
                "isCorrect": false,
                "content": "Incorrect. Furosemide is a loop diuretic used to manage ascites and fluid overload in cirrhosis. It does not treat the underlying cause of hepatic encephalopathy, which is hyperammonemia, and can worsen electrolyte imbalances."
            },
            {
                "dropdownId": "dropdown3",
                "option": "neomycin",
                "isCorrect": false,
                "content": "Incorrect. Neomycin is an antibiotic that can reduce ammonia-producing bacteria in the gut, but it is a second-line therapy due to significant risks of nephrotoxicity and ototoxicity. Lactulose is the first-line treatment."
            },
            {
                "dropdownId": "dropdown3",
                "option": "lactulose",
                "isCorrect": true,
                "content": "Correct. Lactulose is the first-line pharmacological treatment for hepatic encephalopathy. It works by creating an acidic environment in the colon, which converts ammonia to non-absorbable ammonium, promoting its excretion in the stool."
            },
            {
                "dropdownId": "dropdown3",
                "option": "albumin",
                "isCorrect": false,
                "content": "Incorrect. Albumin is administered to cirrhotic patients to manage ascites or hepatorenal syndrome by increasing intravascular oncotic pressure. It does not directly lower serum ammonia levels and is not the primary treatment for encephalopathy."
            }
        ],
        "clinicalPearls": [
            "Asterixis, or 'liver flap,' is a classic sign of hepatic encephalopathy. It is a tremor of the hand when the wrist is extended, sometimes said to resemble a bird flapping its wings.",
            "The goal of lactulose therapy is to produce 2-3 soft stools per day. The nurse must closely monitor bowel movement frequency and consistency to titrate the dose effectively.",
            "Fetor hepaticus, a sweet, fecal odor on the breath, is a late sign of hepatic encephalopathy caused by the exhalation of mercaptans, which accumulate when the liver fails to metabolize methionine."
        ],
        "questionTrap": {
            "trap": "Focusing solely on the diagnosis of pancreatitis and its associated symptoms (pain, elevated amylase/lipase) can cause the test-taker to miss the more immediate life-threatening complication of hepatic encephalopathy, signaled by the neurological changes.",
            "howToOvercome": "Always prioritize the ABCs (Airway, Breathing, Circulation), followed by neurological status. An acute change in level of consciousness is a critical finding that often takes precedence over other systemic issues. Synthesize all data points—labs, physical exam, and history—to identify the most urgent problem."
        },
        "mnemonic": {
            "title": "HEAL for Hepatic Encephalopathy",
            "expansion": "H - History of liver disease. E - Encephalopathy signs (confusion, asterixis). A - Ammonia level is high. L - Lactulose is the treatment."
        }
    },
    "responseOptions": [
        {
            "id": "dropdown1",
            "options": [
                "80",
                "120",
                "180",
                "250"
            ],
            "correctResponse": "180"
        },
        {
            "id": "dropdown2",
            "options": [
                "improved",
                "unchanged",
                "declining",
                "stable"
            ],
            "correctResponse": "declining"
        },
        {
            "id": "dropdown3",
            "options": [
                "furosemide",
                "neomycin",
                "lactulose",
                "albumin"
            ],
            "correctResponse": "lactulose"
        }
    ]
}